endpoint Clinical
The interactive response technology (IRT) company named Catherine Hall as its vice president of product strategy.
Backed by 17 years of clinical supply chain experience, she will lead the company’s global product strategy, including product vision, product execution, team development, and product culture.
Hall told us, “In my career, I have sought to understand the various roles and effort that is needed to conduct a clinical trial from beginning to end. I want to bring those learnings to endpoint so that our teams get to know who all is using our software and why so that we can better match their needs with new technology.
“With users in mind, I want to help develop a robust and innovative product roadmap that anticipates the needs of our users and helps transform clinical trials.
Hall began her career as an academic scientist in Molecular and Cellular Biology before finishing her MBA and transitioning into Supply Chain working with Pfizer/ Millennium/Takeda, Biogen/ Alnylam and Sunovion.
Most recently, Hall was the director of operational excellence at Sunovion Pharmaceuticals’ office of R&D strategic planning. She began her career in academia before recieving her MBA and moving into supply chain, working with Pfizer, Millennium, Takeda, Biogen, and others.